Muhammad Baghdadi

バグダーディームハンマド | Muhammad Baghdadi

Affiliation and department：
Homepage URL (1)： https://kaken.nii.ac.jp/d/r/60711570.ja.html

Research field (1)： Tumor diagnostics and therapeutics

Papers (31)：

Muhammad Baghdadi, Kozo Ishikawa, Sayaka Nakanishi, Tomoki Murata, Yui Umeyama, Takuto Kobayashi, Yosuke Kameda, Hiraku Endo, Haruka Wada, Bjarne Bogen, et al. A role for IL-34 in osteolytic disease of multiple myeloma. Blood advances. 2019. 3. 4. 541-551
Muhammad Baghdadi, Hiraku Endo, Atsushi Takano, Kozo Ishikawa, Yosuke Kameda, Haruka Wada, Yohei Miyagi, Tomoyuki Yokose, Hiroyuki Ito, Haruhiko Nakayama, et al. High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers. Scientific Reports. 2018. 8. 1
Muhammad Baghdadi, Yui Umeyama, Naoki Hama, Takuto Kobayashi, Nanumi Han, Haruka Wada, Ken-ichiro Seino. Interleukin-34, a comprehensive review. Journal of leukocyte biology. 2018. 104. 5. 931-951
Muhammad Baghdadi, Kozo Ishikawa, Hiraku Endo, Yui Umeyama, Tsukasa Ataka, Haruka Wada, Yumiko Oyamada, Naoki Hyakushima, Ken-ichiro Seino. Enhanced expression of IL-34 in an inflammatory cyst of the submandibular gland: a case report. Inflammation and Regeneration. 2018. 38. 12. 12-12
Naoki Hama, Nanumi Han, Muhammad Baghdadi, Ken-ichiro Seino. A new target of Immunotherapy, IL-34. Japan Research Association for Immunotherapy. 2018. 6. 3-6

ｍore...

MISC (1)：

Muhammmad Baghdadi, Ken-ichiro Seino. Therapeutic potential of IL-34 in cancer treatment. Clinical Immunology & Allergology. 2018. 70. 4. 422-428

Books (3)：

iPS細胞の安全・高品質な作製技術
技術情報協会 2016 ISBN:9784861046292
Hematopoietic Differentiation of Human Pluripotent Stem Cells
Springer 2015 ISBN:9789401773119
Cancer Immunology: A Translational Medicine Textbook
Springer 2015 ISBN:9783662440056

Lectures and oral presentations (7)：

A potential role for interleukin-34 in immunotherapeutic resistance of cancer
(The 16th Annual Meeting of Japan Research Association for Immunotherapeutics 2019)
がん治療抵抗性におけるIL-34の役割
(第4回 AMEDがん若手研究者ワークショップ 2019)
免疫学の医療への応用:腫瘍免疫における最新知見
(第8回北海道免疫疾患談話会 2018)
Interleukin-34, がんの治療標的としての可能性
(第14回北海道癌免疫制御研究会 2018)
IL-34 correlates with therapeutic resistance, disease progression, and poor survival in lung cancers
(The 22nd Annual Meeting of Japanese Association of Cancer Immunology 2018)

ｍore...

Education (1)：

2009 - 2013 Hokkaido University Graduate School of Medicine Department of Medical Oncology

Professional career (1)：

PhD (Hokkaido University Graduate School of Medicine)

Work history (3)：

2017/04 - 現在 Hokkaido University Institute for Genetic Medicine Lecturer
2014/06 - 2017/03 Hokkaido University Institute for Genetic Medicine Assistant professor
2013/04 - 2014/05 Hokkaido University Institute for Genetic Medicine Postdoctoral Researcher

Association Membership(s) (4)：

The Japanese Association of Cancer Immunology (JACI) , The Japanese Society for Immunology (JSI) , The Japanese Cancer Association (JCA) , Japan Research Association for Immunotherapeutics

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page